𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hydroxyurea use during pregnancy: A case report in sickle cell disease and review of the literature

✍ Scribed by Diav-Citrin, Orna; Hunnisett, Laura; Sher, Graham D.; Koren, Gideon


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
19 KB
Volume
60
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

✦ Synopsis


A patient being treated for sickle cell disease with hydroxyurea (1 g/d) conceived, and drug treatment was discontinued at nine weeks gestational age. The pregnancy and delivery were complicated by vaso-oclusive crises. A healthy male infant was born at 39 weeks with no evidence of congenital malformations. A literature review, including this case, suggests that the risk of hydroxyurea exposure during in pregnancy may have been overestimated. Further studies are required to determine its safety in pregnancy.


πŸ“œ SIMILAR VOLUMES


Tophaceous gout in a patient with sickle
✍ Robert D. Leff; Marlene A. Aldo-Benson; Rose Spitz Fife πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 193 KB πŸ‘ 1 views

Secondary gout is a recognized complication of several hematologic disorders, including many chronic hemolytic anemias characterized by increased purine metabolism. However, gouty arthritis has been described in only a few patients with hemoglobinopathies, and the identification of typical monosodiu

Phenelzine use throughout pregnancy and
✍ Barbara L. Gracious; Katherine L. Wisner πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 59 KB πŸ‘ 1 views

## Little is known about the use of monoamine oxidase inhibitors (MAOIs) during pregnancy and the postpartum period. We present a literature review with what we believe is the second case report of phenelzine exposure throughout pregnancy and the postpartum period. Potential indications for use and

Multiple granular cell tumor: A case rep
✍ Brett Vean Curtis; Thomas C. Calcaterra; Walter F. Coulson πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 152 KB πŸ‘ 2 views

Background. Granular cell tumor was first described by Abrikossoff in 1926. It is rare and usually presents as a benign solitary lesion. Multifocal and malignant forms are known to occur. Methods. This presentation illustrates an additional case of granular cell tumor. Clinical and histological fea